In contrast, the signal transducer and neural stem cell marker CD24 significantly correlates with a more favorable prognosis of glioma patients, and it has been suggested that it may be a marker that is specifically upregulated in IDH-mutated gliomas [83]. Here, CD24 is linked to central nervous system cancer.